‹ Screener

BNB PLUS CORP.

BNBX · Services-Testing Laboratories · 7.2M shares · -81%/yr ↓ buyback · EDGAR filings ↗

Grade

D45

gen composite 15pct→48; net margin <-100%; net + operating loss

Notable findings

Quarterly revenue

2025-06-30 · $304K2025-09-30 · $199K2025-12-31 · $565K2026-03-31 · $1M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
39.3%
Operating margin
-750.9%
Net margin
-709.5%
Return on equity
-657.8%
Return on assets
-341.7%
ROIC
-550.0%
Revenue growth (QoQ)
34.3%
Current ratio
0.9×
EBITDA
-$16M
Tangible book value
$2M
Cash & investments
$2M
Stock comp / revenue
4.8%

Leadership & compensation

NameRoleLatest total comp
Shorrock ClayChief Executive Officer
Jantzen BethChief Financial Officer
CATELL ROBERT BDirector
Ceccoli Joseph D.Director
Haft JamesDirector
Kruger JoshuaDirector
Murrah JudithDirector
Schmalz Elizabeth MDirector
SHAMASH YACOV ADirector

Officers & directors from SEC filings (Form 4 + DEF 14A proxy); compensation is the latest reported fiscal year.

Notable events (8-K)

DateItems
2026-07-02Material agreementExhibitsfiling ↗
2026-06-253.02filing ↗
2026-06-033.02filing ↗
2026-05-27Material agreement3.023.035.03Reg FDExhibitsfiling ↗
2026-04-29Shareholder votefiling ↗
2026-03-24Delisting noticefiling ↗
2026-02-05Exec/director changeReg FDExhibitsfiling ↗
2026-01-22Exec/director changefiling ↗

Recent filings

FormFiledPeriodAccession
8-K2026-07-022026-06-290001104659-26-080325 ↗
8-K/A2026-06-252026-05-260001104659-26-077784 ↗
8-K/A2026-06-032026-05-260001104659-26-070110 ↗
8-K2026-05-272026-05-260001104659-26-066610 ↗
10-Q2026-05-152026-03-310001104659-26-062596 ↗
8-K2026-04-292026-04-280001104659-26-051503 ↗
DEF 14A2026-03-242026-04-280001104659-26-033866 ↗
8-K2026-03-242026-03-200001104659-26-033842 ↗
10-Q2026-02-122025-12-310001104659-26-014324 ↗
8-K2026-02-052026-02-020001104659-26-010893 ↗
8-K2026-01-222026-01-150001104659-26-005784 ↗
10-K2025-12-222025-09-300001104659-25-123342 ↗